Aida Oncology
Aida uses machine learning and gene expression of individual tumors to help clinicians to prescribe the best drugs for each cancer patient.
Aida Oncology operates in oncology based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2021.
The company sits in the oncology segment, where it competes on its core product or service.
Its base of operations is European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
The company is listed at the Pre_Seed stage of development.
Recorded headcount: c_00001_00010 employees.
Total disclosed funding stands at about $5K.
| Sector | Oncology |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | pre_seed |
| Total funding | $500,000 |
Website: aidaoncology.com
Browse related
Sign in to view the contact information we hold for Aida Oncology.
Create a free account
Create a free account